Wells Fargo’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-115
| Closed | -$1.29K | – | 7507 |
|
2022
Q4 | $1.29K | Buy |
115
+3
| +3% | +$34 | ﹤0.01% | 5784 |
|
2022
Q3 | $1K | Buy |
112
+26
| +30% | +$232 | ﹤0.01% | 6224 |
|
2022
Q2 | $0 | Buy |
+86
| New | – | ﹤0.01% | 7553 |
|
2022
Q1 | – | Sell |
-3,851
| Closed | -$70K | – | 7592 |
|
2021
Q4 | $70K | Buy |
+3,851
| New | +$70K | ﹤0.01% | 5378 |
|
2021
Q3 | – | Sell |
-127
| Closed | -$2K | – | 7418 |
|
2021
Q2 | $2K | Sell |
127
-1,757
| -93% | -$27.7K | ﹤0.01% | 6247 |
|
2021
Q1 | $34K | Sell |
1,884
-11,076
| -85% | -$200K | ﹤0.01% | 5640 |
|
2020
Q4 | $244K | Buy |
12,960
+7,505
| +138% | +$141K | ﹤0.01% | 4857 |
|
2020
Q3 | $115K | Sell |
5,455
-1,345
| -20% | -$28.4K | ﹤0.01% | 5014 |
|
2020
Q2 | $196K | Buy |
6,800
+2,895
| +74% | +$83.4K | ﹤0.01% | 4760 |
|
2020
Q1 | $137K | Buy |
3,905
+3,446
| +751% | +$121K | ﹤0.01% | 4723 |
|
2019
Q4 | $11K | Buy |
+459
| New | +$11K | ﹤0.01% | 5558 |
|